WO2023068343A1 - 飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法 - Google Patents

飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法 Download PDF

Info

Publication number
WO2023068343A1
WO2023068343A1 PCT/JP2022/039193 JP2022039193W WO2023068343A1 WO 2023068343 A1 WO2023068343 A1 WO 2023068343A1 JP 2022039193 W JP2022039193 W JP 2022039193W WO 2023068343 A1 WO2023068343 A1 WO 2023068343A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
food
antibody
supplement
grapefruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2022/039193
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
美幸 徳田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2022/038816 external-priority patent/WO2023068282A1/ja
Application filed by Individual filed Critical Individual
Priority to JP2023554744A priority Critical patent/JPWO2023068343A1/ja
Publication of WO2023068343A1 publication Critical patent/WO2023068343A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • the present invention relates to food and drink, food additives, supplements, cosmetics, antibodies, pharmaceuticals, and methods for producing the same.
  • the cosmetic product of the present invention is preferably in at least one of spray, cream, liquid, gel, paste, emulsion, and mousse.
  • the spray form preferably includes a skin spray.
  • the cream preferably includes at least one of skin cream, lip cream, nasal cavity cream, and eye cream.
  • the antibody is preferably an antibody produced outside the human body. Said antibody preferably comprises an IgY antibody and/or an IgG antibody.
  • FIG. 1 is a diagram showing an antibody 1, a food or drink 10, a food additive 20, a supplement 30, a medicine 40, and a cosmetic 50 according to an embodiment of the present invention.
  • the antibody (for example, immunoglobulin) 1 is a glycoprotein molecule produced by B cells among lymphocytes, and has the function of recognizing and binding to a molecule (antigen) such as a specific protein.
  • Antibody 1 is mainly present in blood and body fluids, and recognizes and binds to, for example, bacteria, viruses, and cells infected with microorganisms that have invaded the body as antigens.
  • phagocytic cells such as leukocytes and microphages recognize and phagocytize the complex of the antigen and Antibody 1 and work to remove it from the body, and immune cells such as lymphocytes bind and become immune. It is something that provokes a reaction.
  • the food and drink 10, the food additive 20, the supplement 30, and the medicine 40 of the present invention are preferably heated and sterilized in a low-temperature atmosphere of 50°C to 65°C (the food and drink 10, the food additive 20,
  • the supplement 30 and the medicine 40 are preferably manufactured by a manufacturing method in which they are heated and sterilized in a low temperature atmosphere of 50° C. to 65° C.).
  • the sterilization time is preferably within 60 minutes. That is, when antibody 1 is treated in a high-temperature atmosphere for a long time, protein denaturation may occur, but sterilization is performed in a low-temperature atmosphere of 50 to 65 ° C., and the sterilization time is within 60 minutes. This can suppress the occurrence of protein denaturation.
  • the cosmetic product 50 of the present invention is preferably in at least one of spray, cream, liquid, gel, paste, emulsion, and mousse. That is, by providing the cosmetic product 50 in such a form, it can be used for various purposes.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PCT/JP2022/039193 2021-10-21 2022-10-20 飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法 Ceased WO2023068343A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023554744A JPWO2023068343A1 (https=) 2021-10-21 2022-10-20

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021-172752 2021-10-21
JP2021172752 2021-10-21
PCT/JP2022/038816 WO2023068282A1 (ja) 2021-10-21 2022-10-18 飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法
JPPCT/JP2022/038816 2022-10-18

Publications (1)

Publication Number Publication Date
WO2023068343A1 true WO2023068343A1 (ja) 2023-04-27

Family

ID=86058293

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/039193 Ceased WO2023068343A1 (ja) 2021-10-21 2022-10-20 飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法

Country Status (2)

Country Link
JP (1) JPWO2023068343A1 (https=)
WO (1) WO2023068343A1 (https=)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001017122A (ja) * 1999-07-12 2001-01-23 Taiyo Kagaku Co Ltd 消化器系炎症予防用食品
JP2002316943A (ja) * 2001-04-17 2002-10-31 Pharmafoods Kenkyusho:Kk 抗ニキビ組成物及びそれを含有するニキビ用化粧料
JP2007082469A (ja) * 2005-09-22 2007-04-05 En Otsuka Pharmaceutical Co Ltd 口腔ケア用飲食品
JP2007185134A (ja) * 2006-01-12 2007-07-26 Asama Chemical Co Ltd 容器詰飲料およびそれらの製造方法
US20210238261A1 (en) * 2018-08-17 2021-08-05 Industry Academic Cooperation Foundation, Hallym University Monoclonal antibody against s protein of mers-coronavirus, and use of same
WO2021181994A1 (ja) * 2020-03-10 2021-09-16 デンカ株式会社 ＳＡＲＳ－ＣｏＶ－２の構造タンパク質に対する抗体のエピトープ、該エピトープに反応する抗体、該抗体を用いてＳＡＲＳ－ＣｏＶ－２を検出する方法、該抗体を含むＳＡＲＳ－ＣｏＶ－２検出キット、該エピトープのポリペプチドを含む抗ＳＡＲＳ－ＣｏＶ－２抗体を検出する方法、該エピトープのポリペプチドを含む抗ＳＡＲＳ－ＣｏＶ－２抗体検出キット、該エピトープのポリペプチドを含むＳＡＲＳ－ＣｏＶ－２用ワクチン及び該抗体を含むＳＡＲＳ－ＣｏＶ－２感染症治療薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4408764B2 (ja) * 2004-07-27 2010-02-03 アサマ化成株式会社 ＩｇＧ抗体含有明らか食品の製造方法
JP4974709B2 (ja) * 2007-02-28 2012-07-11 日油株式会社 皮膚化粧料

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001017122A (ja) * 1999-07-12 2001-01-23 Taiyo Kagaku Co Ltd 消化器系炎症予防用食品
JP2002316943A (ja) * 2001-04-17 2002-10-31 Pharmafoods Kenkyusho:Kk 抗ニキビ組成物及びそれを含有するニキビ用化粧料
JP2007082469A (ja) * 2005-09-22 2007-04-05 En Otsuka Pharmaceutical Co Ltd 口腔ケア用飲食品
JP2007185134A (ja) * 2006-01-12 2007-07-26 Asama Chemical Co Ltd 容器詰飲料およびそれらの製造方法
US20210238261A1 (en) * 2018-08-17 2021-08-05 Industry Academic Cooperation Foundation, Hallym University Monoclonal antibody against s protein of mers-coronavirus, and use of same
WO2021181994A1 (ja) * 2020-03-10 2021-09-16 デンカ株式会社 ＳＡＲＳ－ＣｏＶ－２の構造タンパク質に対する抗体のエピトープ、該エピトープに反応する抗体、該抗体を用いてＳＡＲＳ－ＣｏＶ－２を検出する方法、該抗体を含むＳＡＲＳ－ＣｏＶ－２検出キット、該エピトープのポリペプチドを含む抗ＳＡＲＳ－ＣｏＶ－２抗体を検出する方法、該エピトープのポリペプチドを含む抗ＳＡＲＳ－ＣｏＶ－２抗体検出キット、該エピトープのポリペプチドを含むＳＡＲＳ－ＣｏＶ－２用ワクチン及び該抗体を含むＳＡＲＳ－ＣｏＶ－２感染症治療薬

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GO CAMILLE CELESTE, PANDAV KRUNAL, SANCHEZ-GONZALEZ MARCOS A, FERRER GUSTAVO: "Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series", CUREUS, CUREUS INC., US, 3 November 2020 (2020-11-03), US , XP093056418, ISSN: 2168-8184, DOI: 10.7759/cureus.11315 *
OHGITANI ERIKO, SHIN-YA MASAHARU, ICHITANI MASAKI, KOBAYASHI MAKOTO, TAKIHARA TAKANOBU, KAWAMOTO MASAYA, KINUGASA HITOSHI, MAZDA O: "Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins", MOLECULES, vol. 26, no. 12, pages 3572, XP093059741, DOI: 10.3390/molecules26123572 *

Also Published As

Publication number Publication date
JPWO2023068343A1 (https=) 2023-04-27

Similar Documents

Publication Publication Date Title
JP2019203012A (ja) 醗酵乳製品およびその使用
JP2018538009A (ja) プロバイオティクスを含む組成物、及びその使用方法
CN114502184A (zh) 防治冠状病毒感染的包括杜英萃取物的药物和食品组合物
JP2022132561A (ja) 加齢に伴う持続的注意力低下の改善用の組成物
JP2008516998A (ja) 可食用酸と／またはその酸性塩とコーヒーを含む薬剤組成物と無毒性コーヒー
JP2014114216A (ja) エストラジオール生成促進剤
JP2013237629A (ja) 末梢血行害改善剤
Saqib et al. Immune boosters to combat zoonotic viral diseases
US20040062762A1 (en) Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk
US11413305B2 (en) Use of agar-derived oligosaccharides for inhibiting growth of Staphylococcus
KR20140106058A (ko) 수용성 연어이리 추출물 및 식물성 유산균을 포함하는 면역 증강용 조성물
WO2023068343A1 (ja) 飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法
WO2023068282A1 (ja) 飲食品、食品添加物、サプリメント、化粧品、抗体、医薬、およびその製造方法
WO1999047006A1 (fr) Aliments, traitements medicaux et methodes visant a favoriser la croissance de lactobacillus bifidus, a prevenir les allergies et a reduire le taux de cholesterol chez l'homme
JP6894838B2 (ja) 脳由来神経栄養因子の産生促進用組成物
JP2022057767A (ja) 殺コロナウイルス剤
JP4716770B2 (ja) 免疫賦活・アレルギー改善剤の製造方法
RU2262350C2 (ru) Вакцина для иммунопрофилактики и иммунотерапии заболеваний человека и животных, вызванных патогенными и условно-патогенными грамотрицательными микроорганизмами кишечной группы и их экзотоксинами, и способ ее получения (варианты), иммуноглобулиновый препарат (варианты) и способ его получения, иммунобиологический препарат, поликомпонентная вакцина
KR101757841B1 (ko) 바이칼린-아연착염을 포함하는 비만억제용 조성물
KR102470357B1 (ko) 락토코커스 락티스 q1 균주를 포함하는 면역증진용 조성물
JP2007131579A (ja) 生理活性組成物及びその製造方法
KR102688200B1 (ko) 돈카츠 제조를 위한 육류의 가공방법
JP6358692B2 (ja) タイトジャンクション形成促進剤
JP2014208597A (ja) 爪におけるセラミド含量増加剤
JP2024143365A (ja) 抗ウイルス剤、抗ウイルス用食品組成物及び抗ウイルス用化粧料組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22883646

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2023554744

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22883646

Country of ref document: EP

Kind code of ref document: A1